Kapil secures patent protection for a range of clients, acting principally before the European Patent Office (EPO) and with a focus on the life sciences. He drafts, files and prosecutes patent applications, including cases relating to antibody technologies, gene therapy, microvesicles and plant biotechnology.
Following on from research into the early development and molecular programming of blood, Kapil has a particular interest in patent work in the area of stem cells, acting in particular for UK, US, and Japanese-based companies and academic institutions. In this regard, he handles a variety of stem cell technologies, for example relating to therapies derived from amniotic fluid and the production of various tissues from reprogrammed cells. He also has also developed an interest in Cleantech, in particular working to help secure protection for a successful carbon capture company.
Kapil has been involved in defending successfully patents before the EPO’s Opposition Division and Boards of Appeal, including as lead advocate and as part of a large team on a high-profile case involving parallel national infringement proceedings. He has also been involved in providing Freedom to Operate opinions. Further afield, Kapil has directed large worldwide patent filing and surveillance programmes, covering both major and more esoteric markets.
Kapil is based at our Oxford office, but also works from our London office.
Kapil joined J A Kemp in 2012 and qualified as a European Patent Attorney and UK Patent Attorney in 2017.
University of Bristol, Honours Degree in Biochemistry (with a year spent in the pharmaceutical industry); University of Oxford, DPhil in Molecular Genetics and Developmental Biology
European Patent Attorney; UK Chartered Patent Attorney
Member of the Chartered Institute of Patent Attorneys (CIPA)